SCHEMBL11207308

SCHEMBL11207308

CCOC(=O)c1c(O)cc(O)cc1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 1.00
NR1H3 Q13133 1/20 1.00
CYP3A4 P08684 6/20 0.82
TDP1 Q9NUW8 2/20 0.82
SMN1; SMN2 Q16637 1/20 0.82
CA12 O43570 6/20 0.68
CA1 P00915 6/20 0.68
CA2 P00918 6/20 0.68
CA7 P43166 6/20 0.68
CA9 Q16790 6/20 0.68
CA14 Q9ULX7 6/20 0.68
HPGD P15428 2/20 0.64
KDM4E B2RXH2 1/20 0.59
MEN1 O00255 2/20 0.55
KMT2A Q03164 2/20 0.55
PTGS1 P23219 1/20 0.55
DRD3 P35462 1/20 0.55
ACHE P22303 1/20 0.53
ESR1 P03372 1/20 0.52
ESR2 Q92731 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Orsellinic Acid, Ethyl Ester SCHEMBL1648471 0.90 CYP3A4 (1.00) NR1H2NR1H3CYP3A4TDP1SMN1; SMN2
SCHEMBL9751189 0.88 NR1H2 (0.78) NR1H2NR1H3CYP3A4TDP1SMN1; SMN2
SCHEMBL20378742 0.86 NR1H2 (0.75) NR1H2NR1H3CYP3A4TDP1SMN1; SMN2
SCHEMBL31222830 0.86 NR1H2 (0.74) NR1H2NR1H3CYP3A4TDP1SMN1; SMN2
SCHEMBL10728229 0.84 NR1H2 (0.72) NR1H2NR1H3CYP3A4TDP1SMN1; SMN2
SCHEMBL19409973 0.84 NR1H2 (0.72) NR1H2NR1H3CYP3A4TDP1SMN1; SMN2
SCHEMBL12207101 0.83 CYP3A4 (0.82) NR1H2NR1H3CYP3A4TDP1SMN1; SMN2
SCHEMBL11315535 0.83 NR1H2 (0.71) NR1H2NR1H3CYP3A4TDP1SMN1; SMN2
SCHEMBL24565087 0.83 NR1H2 (0.70) NR1H2NR1H3CYP3A4TDP1SMN1; SMN2
SCHEMBL11315559 0.83 NR1H2 (0.70) NR1H2NR1H3CYP3A4TDP1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118126635-A Instant adhesive for glass lamination process 东莞市斗牛士胶粘制品有限公司 2024-06-04 CN claimed
CN-115612699-B Copolymer membrane, and enzymatic self-assembly synthesis method and application thereof in gas-liquid interface 中国科学院天津工业生物技术研究所 2024-10-25 CN disclosed
CN-118126635-A Instant adhesive for glass lamination process 东莞市斗牛士胶粘制品有限公司 2024-06-04 CN disclosed
CN-115612114-B Copolymer membrane and method for enzymatic self-assembly synthesis and application thereof 中国科学院天津工业生物技术研究所 2024-02-20 CN disclosed
CN-115612403-B Self-assembled strong-adhesion copolymer film, coating method and application 中国科学院天津工业生物技术研究所 2023-12-01 CN disclosed
CN-116845483-B Composite diaphragm, preparation method thereof and secondary battery 天津市捷威动力工业有限公司 2023-11-28 CN disclosed
CN-116845483-A Composite diaphragm, preparation method thereof and secondary battery 天津市捷威动力工业有限公司 2023-10-03 CN disclosed
US-20210171883-A1 ANTIVIRAL WIPER FUJIFILM CORPORATION (JP) 2021-06-10 US disclosed
EP-0015592-B1 LIGHT-SENSITIVE SILVER HALIDE MATERIALS COMPRISING FLUORINE-CONTAINING SURFACTANTS AGFA-GEVAERT N.V. (BE) 1983-08-10 EP disclosed
US-4292402-A UNIFORM COATINGS FOR HYDROPHILIC COLLOID LAYERS; ANTISTATIC AGENTS AGFA-GEVAERT, N.V. (BE) 1981-09-29 US disclosed
EP-0015592-A1 Light-sensitive silver halide materials comprising fluorine-containing surfactants AGFA-GEVAERT N.V. (BE) 1980-09-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210171883-A1 ANTIVIRAL WIPER CGAS, PRKX, PDE4C NR1H2 4451/4885NR1H3 4469/4885CYP3A4 4047/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.